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Abstract
MBP-1 acts as a general transcriptional repressor. Overexpression of MBP-1 induces cell death in a number of cancer cells
and regresses tumor growth. However, the function of endogenous MBP-1 in normal cell growth regulation remains
unknown. To unravel the role of endogenous MBP-1, we knocked down MBP-1 expression in primary human foreskin
fibroblasts (HFF) by RNA interference. Knockdown of MBP-1 in HFF (HFF-MBPsi-4) resulted in an induction of premature
senescence, displayed flattened cell morphology, and increased senescence-associated beta-galactosidase activity. FACS
analysis of HFF-MBPsi-4 revealed accumulation of a high number of cells in the G1-phase. A significant upregulation of
cyclin D1 and reduction of cyclin A was detected in HFF-MBPsi-4 as compared to control HFF. Senescent fibroblasts
exhibited enhanced expression of phosphorylated and acetylated p53, and cyclin-dependent kinase inhibitor, p21. Further
analysis suggested that promyolocytic leukemia protein (PML) bodies are dramatically increased in HFF-MBPsi-4. Together,
these results demonstrated that knockdown of endogenous MBP-1 is involved in cellular senescence of HFF through p53-
p21 pathway.
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Introduction
MBP-1, an ,37 kDa cellular protein, has multiple functions. It
binds to the c-myc promoter sequences and transcriptionally
represses the c-myc gene. MBP-1 acts as a general transcriptional
repressor [1–3]. Sequence analysis suggested that MBP-1 has a
high homology with ENO1 cDNA, an ,48 kDa protein,
designated as human enolase cDNA [1, 4]. However, the enolase
enzymatic activity was not demonstrated from this ENO1 cDNA
clone. Whether full length ENO1 gene product has a similar
function like MBP-1 in carcinoma cells is yet to be determined.
However, most of the studies to date used MBP-1 cDNA which
expresses ,37 kDa protein. Structure/function analysis of MBP-1
mutants revealed that the transcriptional repressor domains are
located in the amino-terminal (MBP-AR) and carboxy-terminal
(MBP-CR) regions. We have demonstrated that MBP-1 exerts an
anti-proliferative effect on a number of cancer cell lines and
inhibits tumor growth in nude mice [5, 6]. While the role of
exogenous expression of MBP-1 in the transcription and cell
growth regulation appear to be established, the in vivo function of
this protein is poorly understood.
Normal human cells respond to certain types of DNA damage
caused by histone deacetylase inhibitors (which remodel chroma-
tin) and oncogenic forms of Ras or Raf (which transduce mitogenic
signals) by adopting a phenotype that closely resembles replicative
senescence [7]. On the other hand, immortalized cells tend to
respond to DNA damage or oncogenes by undergoing apoptosis or
neoplastic transformation. Cell senescence is defined as prolifer-
ative arrest that occurs in normal cells after a limited number of
cell division. Cells that underwent senescence cannot divide even if
stimulated by mitogens, but they remain metabolically active and
show characteristic changes in morphology, such as enlarged and
flattened cell shape and increased granularity [8]. Senescence is
controlled by two major tumor suppressors, the p53 gene and the
retinoblastoma (Rb) gene [9–11]. An increase in p53 transcrip-
tional activity is a molecular signature for cellular senescence. The
increased activity is driven by changes in p53 phosphorylation and
acetylation status [12, 13]. The senescent-associated growth arrest
is due to the downregulation of selected positive-acting cell cycle
regulatory genes. The activities of cyclin-dependent kinase 2
(Cdk2) and cyclin-dependent kinase 4 (Cdk4) are greatly reduced,
due to the increased expression of the Cdk inhibitor proteins p21,
and p16, causing Rb to be present in its hypophosphorylated form.
In this study, we have uncovered a novel function of
endogenous MBP-1. Knockdown of MBP-1 in human primary
fibroblasts induced premature senescence involving the p53-p21
signaling pathway.
Results
Knockdown of endogenous MBP-1 in human foreskin
fibroblasts results in decreased cell proliferation
To investigate the role of endogenous MBP-1 in cellular
proliferation, we knocked down endogenous MBP-1 in human
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used several siRNAs, and two of them efficiently knockdown MBP-1
expression [14]. For generation of stable clone, we constructed a
plasmid DNA vector expressing a potent shRNA targeted to MBP-1
coding region or scrambled shRNA. HFFs were transfected with the
plasmid DNA pRNAH1.1-MBPsi-4 (HFF-MBPsi-4) or scrambled
shRNA (HFF-control), selected for neomycin resistant colonies and
pooled to avoid clonal selection. Cell lysates were prepared for
Western blot analysis to detect endogenous expression of MBP-1
using a specific antibody. We observed 95% inhibition of MBP-1 in
HFF-MBPsi-4 as compared with that of HFF-control (Fig. 1, panel
A). Similar results were obtained using MBPsi-3, suggesting that
observed effect is not off-target. We have also used three different
pools of transfectants and observed similar results. For subsequence
studies, we have utilized HFF-MBPsi-4. We examined whether
knockdown of MBP-1 has an effect on cell proliferation. For this, cell
proliferation of MBP-1 knockdown HFF was determined after
antibiotic selection. HFF-MBPsi-4 exhibited a significantly slower
rate of proliferation as compared with the HFF-control suggesting
that depletion of MBP-1 inhibited cell proliferation (Fig. 1, panel B).
Senescent cells remained viable for 8 weeks, and then slowly
disintegrated. Human primary fibroblasts generally display senes-
cence after 70–80 passages. Next, we examined whether knockdown
of MBP-1 modulates cell cycle progression in HFF-MBPsi-4 by
FACS analysis. An equal number of HFF or HFF-MBPsi-4 (10
5 cells)
were seeded and grown for 24 h. Cells were then trypsinized and
stained withpropidiumiodide forFACSanalysis(Fig.1,panel C).An
approximately 80% of HFF-MBPsi-4 cells accumulated in G1 phase
as compared to ,60% of control fibroblasts. Cells accumulated in the
G2/M phase did not exhibit a significant difference between the
control and HFF-MBPsi-4. However, we observed a ,3-fold
reduction in the number of HFF-MBPsi-4 accumulated in the S-
phase of the cell cycle as compared to that of the control cells.
Together, our results suggested that MBP-1 knockdown interrupts
progression of the cell cycle from the G1 to S phase in normal HFFs.
Inhibition of MBP-1 in HFF induces premature
senescence
During the period of monitoring cell viability, we observed that
HFF-MBPsi-4 was growing larger in size. To ascertain our
observation, we plated an equal number of control HFF and HFF-
MBPsi-4. Cells were grown to confluency and stained with
hematoxylin and eosin (H & E). HFF-MBPsi-4 diaplayed increased
in size as compared to HFF-control cells (Fig. 2, panel A) using
light microscopy under same magnification. We have also
observed that MBP-1 knocked down HFFs displayed a flattend
cellular morphology with progressive cell passage. To investigate
whether MBP-1 knockdown leads to growth arrest, HFF-control
or HFF-MBPsi-4 were plated for senescence associated b-
galactosidase assay (SA-b-gal). Detection of b-galactosidase activity
at pH 6.0 is a known characteristic of senescent cells. After 48 h,
cells were fixed and stained with X-gal for the detection of b-
galactosidase activity (Fig. 2, panel B). More than 70% of HFF-
MBPsi-4 displayed appearance of enlarged blue cells (panel a) in
contrast to the control HFF cells, which failed to exhibit a
detectable blue appearance (panel b). Therefore, these results
suggested that knockdown of MBP-1 leads HFFs to undergo
premature senescence.
Knockdown of MBP-1 in HFF is associated with the
modulation of cyclins
HFF-MBPsi-4 and HFF-control lysates were analyzed for the
expression of cyclin D1, cyclin E, and cyclin A using specific
antibodies. We have observed that cyclin D1 and cyclin E
expression was significantly upregulated (4 and 2 fold, respectively)
in HFF-MBPsi-4 as compared to HFF-control (Fig. 3, panel A).
However, cyclin A expression was markedly lower (,3 fold) in
MBP-1 knockdown HFF. Next, HFF-MBPsi-4 and HFF- control
were synchronized by serum starvation and cell lysates were
prepared at 0, 6, 12, 18, and 24 h following serum stimulation.
The lysates were analyzed for the expression of cyclin D1. The
basal level (0 h) of cyclin D1 in control HFF was significantly lower
(,4-fold) than the HFF-MBPsi-4. Elevated levels of cyclin D1
were detected in the HFF-control between 6–12 h which decreases
afterwards. In contrast, the level of cyclin D1 expression in HFF-
MBPsi-4 was increasing with time (Fig. 3, panel B). Senescent
human cells generally arrest growth with a G1 DNA content, and
cannot be stimulated to divide by physiological mitogens. Higher
expression of cyclin D1 in HFF-MBPsi-4 further suggested the
permanent growth arrest in HFF upon knockdown of MBP-1.
Post-translational modification of p53 occurs in MBP-1
knockdown HFF
An increase in p53 transcriptional activity is a molecular
signature for cellular senescence. The increased activity is driven
by changes in p53 phosphorylation (at Ser15) and acetylation (at
Lys382) status [12, 13]. To investigate whether pathway linking
p53 and senescence after knocking down MBP-1 in HFFs, we
examined the post-translational modification of p53 by Western
blot analysis using specific antibodies. We have observed p53
acetylation at Lys382 site and phosphorylation at Ser15 in MBP-1
knockdown HFF (Fig. 4). These results suggest that MBP-1
knockdown in HFF results in activation of p53. Enhancement of
p53 by phosphorylation and/or acetylation results in activation of
its target genes. The cyclin dependent kinase inhibitor, p21 is one
of the p53 target genes. Therefore, we examined whether an
increase in p21 expression in HFF-MBPsi-4 was due to activation
of p53 transcriptional activity. Our results demonstrated a
significant increase in p21 in the HFF-MBPsi-4 as compared to
HFF-control.
Cell cycle regulatory genes are modulated in HFF-MBPsi-
4
To gain mechanistic insights into MBP-1 for cellular functions,
we used a pathway specific gene array to identify MBP-1 target
genes in MBP-1 knockdown HFF by comparison with controls.
We isolated total RNAs from HFF-control and HFF-MBPsi-4 for
studying the influence of endogenous MBP-1 on cell cycle gene
expression using a cell-cycle pathway specific mini array. Growth
inhibition was indicated by an induction of p53 target genes, p21
and GADD45A, and decreased expression of genes driving
progression through various phases of the cell cycle. Notably,
several genes encoding critical components of the DNA replication
machinery (MCM4/MCM5) were down-regulated. A representa-
tive subset of the results is presented in Table 1. Interestingly, we
have observed downregulation of the p27/KIP1 gene in senescent
HFF. On the other hand, Collado et al. [15] have shown that
premature senescence mediated by LY298004 in MEFs display
accumulation of the p27. The difference of these results could be
due to a difference between human vs. mouse cells or mediator
selectively targeting p21 or p27 gene. Lysates from the HFF-
control or HFF-MBPsi-4 were analyzed for expression of p21 and
cyclin D1 by Western blot using specific antibodies. A significant
elevation in p21 and cyclin D1 expression was observed in the
lysates of HFF-MBPsi-4 when compared with control cells (Figs. 3
and 4), which corroborates with our gene array data.
MBP-1 and Senescence
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PML plays a critical role in growth control, transformation
suppression, induction of apoptosis, and replicative senescence
depending on the cellular context. PML is upregulated during
cellular senescence, and induces premature senescence in response
to oncogenic Ras by promoting p53 acetylation [16]. PML is the
defining component of nuclear structures known as promyelocytic
oncogenic domains (PODs). The ability of PML to PODs appears
essential for its prosenescence activity. The accumulation of PODs
in response to oncogenic Ras is coincident with the onset of
premature senescence and appears unique to the senescent state.
To determine whether PML is induced in MBP-1 knockdown
HFF, we conducted immunofluorescence microscopy on HFF-
control and HFF-MBPsi-4 using a PML monoclonal antibody. We
have observed that the PML nuclear bodies increase in size and
number in HFF-MBPsi-4 as compared to HFF-control (Fig. 5),
and may play a pivotal role in the senescence process.
Discussion
The normal cellular function of endogenous MBP-1 remains
unclear. To investigate the endogenous function, we knocked
down MBP-1 expression in HFF by RNA interference. Knock-
down of MBP-1 expression in HFF (.95%) resulted in significant
inhibition of cell proliferation as compared to parental control
cells. Morphological studies after knockdown of MBP-1 revealed
enlarged and flattened cell morphology and positive senescence-
associated b-galactosidase staining, characteristics of senescent
fibroblasts. Cell cycle analysis demonstrated an accumulation of
,80% MBP-1 knockdown cells in the G1-phase as compared to
Figure 1. Knockdown of MBP-1 in human foreskin fibroblasts induces cell proliferation. Panel A: Normal human foreskin fibroblasts
were transfected with MBP-1 specific shRNA or control scrambled shRNA and selected with neomycin for 3 weeks. Colonies were pooled and
examined for endogenous expression of MBP-1 by Western blot analysis using a specific antibody to MBP-1. Densitometric analysis of MBP-1/tubulin
was performed using Image Quant Software (Amersham, ME). Panel B: Knockdown of MBP-1 inhibits HFF proliferation. Cells were plated after
selection, and counted at different time points by trypan blue exclusion method. Panel C: MBP-1 knockdown in HFF results in accumulation of HFF
at the G1 phase. Asynchronized HFF-control and HFF-MBPsi-4 were harvested fixed and stained with propidium iodide. DNA content was analyzed by
flow cytometry. Results are represented as percent of cell population in G1, S, and G2/M phases of the cell cycle. Results are presented together with
standard errors from three independent experiments.
doi:10.1371/journal.pone.0003384.g001
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observed in G2/M phase, only ,7% of MBP-1 knockdown HFF
accumulated in the S-phase as compared to control HFF (20%).
To gain mechanistic insights, we examined the expression level of
different cyclins. A high level expression of cyclin D1 (,4 fold) and
cyclin E (,2 fold) was detected in MBP-1 knockdown HFF as
compared to the control fibroblasts. On the other hand, expression
of cyclin A, one of the target genes of Rb/E2F1 signaling pathway,
was significantly lower (,3 fold) in the senescent fibroblasts.
MBP-1 knocked down fibroblasts displayed enhanced phos-
phorylation and acetylation of p53 suggesting an upregulation of
p53 transcriptional activity. The activity of p53 is regulated by
recruitment into PML-nuclear bodies as well as stabilization
through post-translational modifications, such as phosphorylation
and acetylation. PML nuclear bodies are also implicated in diverse
cellular functions, such as gene regulation, apoptosis, and
senescence. Knockdown of MBP-1 in HFF increased PML
accumulation in the nucleus, which may enhance PML-induced
acetylation of p53 and PML-induced cellular senescence, although
future study is necessary in understanding the detailed mechanism.
Inhibition of superoxide dismutase (SOD) by RNAi induces
premature senescence in normal human fibroblasts [17]. The
senescent fibroblasts displayed elevated expression levels of p53 in
the nucleus. Depletion of DNA methyltransferase in normal
diploid human fibroblasts results in senescent-like growth arrest
and is accompanied by up-regulation of p21 [17]. We have also
observed that the senescent fibroblasts displayed a higher level p21
expression which may inhibit the kinase activities of cyclin D1-
Cdk4/6 and cyclin E-Cdk2 complexes resulting in inhibition of
cell cycle progression. We have observed a significant downreg-
ulation of wild type p21 promoter activity by MBP-1 in HFF as
compared to p53 site mutated p21 promoter in an in vitro reporter
assay. Cyclin D1-Cdk4/6 specific phosphorylation of Rb at
Ser780 was only barely detectable in MBP-1 knockdown HFF,
however p16 was not upregulated (data not shown).
The target genes controlled by endogenous MBP-1 remains
unknown at present. Our results demonstrated that MBP-1 might
regulate these genes through p53. The gene array analysis from
MBP-1 knockdown HFF vs. control HFF yielded an expression
signature that was indeed consistent with the observed phenotype
for MBP-1 knockdown HFF, thereby imparting credibility to our
data. Growth inhibition was indicated by an induction of p53
target gene p21 and decreased expression of genes driving
progression through phases of the cell cycle, such as CDC2 and
CDC20. Notably, several genes encoding critical components of
DNA replication machinery were downregulated. Taken together
these results indicated a role of endogenous MBP-1 in cell survival.
Opposing roles in cell growth were also observed with several
genes, such as KLF4, E2F, VHL, Ras, p75 neurotrophin receptor
(p75
NTR), Maf, and TGF-b [19, 20]. Affar et al [21] recently
Figure 2. Knockdown of MBP-1 in HFF altered morphology and exhibited senescence-associated b-galactosidase expression. Panel
A: HFF-MBPsi-4 (panel a) and HFF-control (panel b) were grown to near confluency and stained with H & E. MBP-1 knockdown fibroblasts displayed
an irregular, enlarged cellular morphology as compared to the control siRNA transfected cells. Panel B: HFF-MBPsi-4 cells and control-HFF were
grown in plates and senescence-associated b-galactosidase assay was performed. MBP-1 knockdown HFF displayed a significantly higher senescence
associated b-galactosidase activity (panel a), unlike in control HFF (panel b).
doi:10.1371/journal.pone.0003384.g002
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and viability in a dose-dependent manner. Inactivation of tumor
suppressor gene BRAC1 was also found embryonically lethal [22].
The HMGA proteins can promote tumorigenesis [23], although
HMGA proteins have recently been shown to specifically
accumulate in senescent cell chromatin, and contribute to the
stable repression of proliferation-associated genes [24]. We have
demonstrated previously that forced expression of MBP-1
negatively regulates cell growth in a number of human cancer
cell lines of various tissue origins [6]. How might these
contradictory activities of MBP-1 be explained? One possibility
stems from the finding that overexpression of MBP-1 in cancer
cells induces cell death, which suppresses tumorigenesis by
inhibiting anti-apoptotic proteins [14, 25]. Here, we have shown
that knockdown of MBP-1 induces premature senescence of
primary human fibroblasts. Two connected yet distinct senescence
pathways have been identified: one consisting of p53-p21 and the
second p16-Rb [26]. Although RasV12-induced senescence
involves both pathways [27], cellular senescence induced by the
knockdown of MBP-1 involved only p53-p21. Knockdown of
MBP-1 in human urothelial cells immortalized by HPV E6 did not
exhibit senescence or upregulation of p21 (data not shown).
However, it remains unclear which upstream stimuli preferentially
use the p53-p21 pathway to trigger senescence. Identification of
other MBP-1 interacting proteins to understand how these
proteins interact with each other in the complex, and to find out
exactly how these proteins interplay with p53 and repress its
transcriptional activity will help to get insights into the normal
physiological function of MBP-1.
Materials and Methods
Cell culture
Human foreskin fibroblasts (HFF) were grown in DMEM
containing 10% fetal bovine serum (FBS) with penicillin/
streptomycin in a 5%-CO2 incubator.
Figure 3. MBP-1 knockdown in HFF modulates expression of cyclins. Panel A: Expression of cyclins in control and MBP-1 knockdown HFF.
Lysates prepared from cells were subjected to Western blot analysis using indicated antibodies. Knockdown of MBP-1 enhanced cyclin D1 expression
and cyclin E and reduced cyclin A expression in HFF-control. Panel B: Time-dependent elevation of cyclin D1 expression in MBP-1 knockdown HFF as
compared to control HFF. Cells were synchronized by serum-starvation and lysates were prepared at different time points as indicated following
serum stimulation. Cell lysates were examined for the expression of cyclin D1 by Western blot analysis using specific antibody. Protein load was
normalized and determined level of cyclin D1 by densitometric analysis. Arbitrary unit was chosen to represent relative cyclin D1 expression. Results
are presented together with standard errors from three independent experiments.
doi:10.1371/journal.pone.0003384.g003
Figure 4. MBP-1 knockdown results in activation of p53 and
p21. Lysates from HFF-control and HFF-MBPsi-4 were subjected to
Western blot analysis by probing with antibodies against MBP-1,
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shRNA
We have identified two potent siRNA sequences targeted to
MBP-1 mRNA [14]. Both the siRNAs targeted to MBP-1
efficiently knockdown MBP-1 expression. We next cloned small
hairpin RNAs (shRNAs) targeting MBP-1 (MBPsi-4) mRNA into a
pRNAH1.1/neo plasmid vector (Genscript) under the control of
the H1 promoter. Control scrambled sequences were used
similarly. Early passage HFF (passage 4) were transfected with a
plasmid DNA expressing MBP-1 specific (HFF-MBPsi-4) or
control shRNA (HFF-control). After 48 h of transfection, cells
were treated with 400 mg/ml G418 for selection of antibiotic-
resistant colonies over a period of 3 weeks. All colonies were
pooled and examined for the expression of endogenous MBP-1 by
Western blot analysis using specific antibody. After selection, cell
growth was measured.
Senescence associated b-galactosidase assay
Equal number of HFF-control and HFF-MBPsi-4 were plated
in 35 mm plates for the senescence associated b-galactosidase
assay, as described earlier [28]. After 48 h, cells were fixed and
stained with X-gal for detection of b-galactosidase activity using a
senescence b-galactosidase staining kit (Cell Signaling). Cells
exhibiting positive b-galatosidase activity (turned blue) at pH 6.0
were counted under a light microscope.
FACS analysis and Western blot analysis
Cells were plated in DMEM containing 10% FBS and grown
overnight. After 24 h, cells were trypsinized and fixed in ice-cold
70% ethanol overnight at 4uC. Cells were washed, stained with
propidium iodide for 2 h and subjected to FACS analysis on a
FACScan flow cytometer (BD PharMingen). Data were analyzed
using the CellQuest and ModFit software. For the analysis of cell
Table 1. Genes differentially expressed in MBP-1 depleted HFF.
Biological Process Gene Name Fold Change Gene Title
G1 Phase and G1/S Transition CCND1 7.46 Cyclin D1
CDK6 4.04 Cyclin-dependent kinase 6
DNA Replication MCM4 23.27 minichromosome maintenance deficient 4
MCM5 23.2 minichromosome maintenance deficient 5
Cell Cycle Checkpoint and Arrest GADD45A 5.35 growth arrest and DNA-damage-inducible 45 alpha
CDKN1A 4.77 cyclin-dependent kinase inhibitor 1A (p21)
BRCA2 23.4 breast cancer 2
CEDKN3 25.45 cyclin-dependent kinase inhibitor
Regulation of Cell Cycle CDKN1B 23.56 cyclin-dependent kinase inhibitor 1B (p27)
CCNB1 23.63 cyclin B1
CCNB2 24.61 cyclin B2
CDC2 24.77 cell division cycle 2 homolog
CDC20 26.57 cell division cycle 20 homolog
RAD9A 27.06 RAD9 homolog
MKI67 27.67 antigen identified by monoclonal antibody Ki 67
Negative Regulation of Cell Cycle RBL1 23.08 retinoblastoma-like 1 (p107)
doi:10.1371/journal.pone.0003384.t001
Figure 5. PODs accumulate during premature senescence in MBP-1 knockdown HFF. PML localization in HFF-control (Panel A) or HFF-
MBPsi-4 (Panel B) was determined by indirect immunofluorescence using the PML monoclonal antibody.
doi:10.1371/journal.pone.0003384.g005
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stimulated by adding complete DMEM containing 10% FBS.
Cells were lysed in 26 SDS-sample buffer following serum
stimulation at 0, 6, 12, 18, and 24 h. Cell lysates were then
subjected to Western blot analyses using specific antibodies to
various cyclins. Cell lysates were also prepared from unsynchro-
nized HFF-control and HFF-MBPsi-4 and analyzed for MBP-1
expression, cyclin-dependent kinase inhibitor (p21), p53, phos-
phorylated and acetylated p53 by Western blot using specific
antibodies. All the antibodies to cyclin D1, cyclin E, cyclin A and
cyclin B1, p21 and p53 were purchased from Santa Cruz
Biotechnology, acetylated p53 (Lys-373/382) from Upstate
Biotechnology, phosphorylated p53 (Ser-15) and phospho-Rb
(Ser-780) from Cell Signaling.
Gene array
We isolated total RNAs from control and MBP-1 knockdown
fibroblast for studying the influence of endogenous MBP-1 on cell
cycle gene expression. Five mg of total RNA was used to produce
cDNA using a First Strand cDNA Synthesis Kit (SuperArray).
Quantitative amplification of the fibroblasts cDNAs was moni-
tored with SYBR Green using real-time PCR. Amplification was
carried out in 25 ml of ROX PCR Master Mix (SuperArray)
containing 0.2 mM of each primer and 1 ml of the reverse
transcription reaction mixture to each well of 96 well cell cycle
array plate in a 7700 Real-time PCR system (Applied Biosystems)
following the manufacturer’s protocol. Data analysis was based on
the DDCt method with normalization of the target genes in MBP-1
knockdown fibroblasts to control fibroblasts. Data was analyzed
using PCR Array data analysis software (SuperArray).
Fluorescence Microscopy
HFF-control and HFF-MBPsi-4 were fixed in 3.5% parafor-
maldehyde for 15 min, permeabilized in 0.2% Triton X-100-PBS
for 5 min, and blocked in 5% BSA in PBS at room temperature
for 1 h. Primary antibody (anti-PML, PG-M3, 1:200, Santa Cruz)
incubation were performed for 1 h at room temperature. After
washing the cells, secondary antibody incubation was performed
with goat anti-mouse immunoglobulin G (IgG)-Alexa Fluor-546
for 45 min at room temperature. Control experiments demon-
strated no detectable staining by secondary antibodies only (data
not shown). Cells were visualized with a Nikon immunofluoros-
cence microscope.
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